VEGF/VEGFR2 pathway is the central therapeutic target in anti-angiogenic treatment in multiple cancers. However, little work has been carried out concerning the pro-malignancy functions of VEGFR2 that are independent of its pro-angiogenesis effects in gastric cancer. | VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenicindependent way in gastric cancer